Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Woochan Park"'
Autor:
Woochan Park, Hongjun An
Publikováno v:
Journal of Astronomy and Space Sciences, Vol 35, Iss 3, Pp 133-141 (2018)
We report on our Galactic plane searches for magnetars in the archival Chandra X-ray Observatory (CXO) data. We summarize the properties of known magnetars and use them to establish a procedure for magnetar searches. The procedure includes four steps
Externí odkaz:
https://doaj.org/article/39fb3b0e3caf4b9aa5a99a606a5fc203
Autor:
Woochan Park, Ja Min Byun, Junshik Hong, Inho Kim, Dong-Yeop Shin, Seonyang Park, Youngil Koh, Sung-Soo Yoon
Publikováno v:
Annals of Hematology. 102:629-639
For relapsed acute myeloid leukemia (AML) patients who received allogeneic hematopoietic stem cell transplantation, donor lymphocyte infusion (DLI) is an effective therapy. However, the cell source of DLI remains a topic of debate. In this study, we
Autor:
Ja Min Byun, Woochan Park, Dong-Yeop Shin, Youngil Koh, Inho Kim, Sung-Soo Yoon, Jae Hyeon Park, Hyungsuk Kim, Junshik Hong
Publikováno v:
Blood Transfusion (17232007); Nov/Dec2023, Vol. 21 Issue 6, p479-487, 9p
Autor:
Woochan Park1, Ju-Hee Bang2, Ah-Rong Nam2, Mei Hua Jin2, Hyerim Seo2, Jae-Min Kim2, Kyoung Seok Oh2, Tae-Yong Kim1,2, Do-Youn Oh1,2 ohdoyoun@snu.ac.kr
Publikováno v:
Cancer Research & Treatment. Jan2021, Vol. 53 Issue 1, p199-206. 8p.
Autor:
Do Youn Oh, Kyoung Seok Oh, Tae Yong Kim, Ah Rong Nam, Hye-Rim Seo, Woochan Park, Jae-Min Kim, Ju Hee Bang, Mei Hua Jin
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The soluble form programmed death-ligand 1 (sPDL1) has immunosuppressive properties and is being studied as a candidate biomarker for immuno-oncology drug development. We measured the serum sPDL1 at pre-and post-chemotherapy and evaluated its
Autor:
Mei Hua Kim, Woochan Park, Do-Youn Oh, Ju-Hee Bang, Ji Eun Park, Yung-Jue Bang, Kyoung Seok Oh, Ah-Rong Nam
Publikováno v:
Journal of Clinical Oncology. 37:4034-4034
4034 Background: The soluble form Programmed Death-Ligand 1(sPDL1) is suggested to have immunosuppressive activity and under investigation as candidate biomarker for immuno-oncology drug development. In this study, we measured the serum sPDL1 at pre-
Autor:
O'Regan, Ruth M., Gajdos, Csaba, Dardes, Rita C., De Los Reyes, Alex, Woochan Park, Rademaker, Alfred W., Jordan, V. Craig, Park, Woochan
Publikováno v:
JNCI: Journal of the National Cancer Institute; 2/20/2002, Vol. 94 Issue 4, p274-283, 10p, 5 Graphs